BOSTON SCIENTIFIC CORP (BSX) Retained Earnings (Accumulated Deficit) USD 2010 - 2024

Historical data

Taxonomy & unit
us-gaap: USD
Description
The cumulative amount of the reporting entity's undistributed earnings or deficit.
Summary
Boston Scientific Corp quarterly Retained Earnings (Accumulated Deficit) history and growth rate from 2010 to 2024.
  • Boston Scientific Corp Retained Earnings (Accumulated Deficit) for the quarter ending March 31, 2024 was $1.31B.
Retained Earnings (Accumulated Deficit), Quarterly Data (USD)
Period Value YoY Chg Change % Date Report Filed
Q1 2024 $1.31B +$1.76B Mar 31, 2024 10-Q 2024-05-01
Q4 2023 $819M +$1.57B Dec 31, 2023 10-Q 2024-05-01
Q3 2023 $315M +$1.19B Sep 30, 2023 10-Q 2023-11-01
Q2 2023 -$189M +$861M +82% Jun 30, 2023 10-Q 2023-08-03
Q1 2023 -$450M +$846M +65.3% Mar 31, 2023 10-Q 2023-05-04
Q4 2022 -$750M +$642M +46.1% Dec 31, 2022 10-K 2024-02-20
Q3 2022 -$876M +$597M +40.5% Sep 30, 2022 10-Q 2022-11-03
Q2 2022 -$1.05B +$828M +44.1% Jun 30, 2022 10-Q 2022-08-04
Q1 2022 -$1.3B +$754M +36.8% Mar 31, 2022 10-Q 2022-05-05
Q4 2021 -$1.39B +$986M +41.5% Dec 31, 2021 10-K 2023-02-23
Q3 2021 -$1.47B +$1.1B +42.8% Sep 30, 2021 10-Q 2021-11-04
Q2 2021 -$1.88B +$527M +21.9% Jun 30, 2021 10-Q 2021-08-06
Q1 2021 -$2.05B +$202M +8.97% Mar 31, 2021 10-Q 2021-05-06
Q4 2020 -$2.38B -$125M -5.55% Dec 31, 2020 10-K 2022-02-23
Q3 2020 -$2.57B +$3.68B +58.8% Sep 30, 2020 10-Q 2020-11-05
Q2 2020 -$2.41B +$3.97B +62.3% Jun 30, 2020 10-Q 2020-08-05
Q1 2020 -$2.25B +$4.28B +65.5% Mar 31, 2020 10-Q 2020-05-06
Q4 2019 -$2.25B +$4.7B +67.6% Dec 31, 2019 10-K 2021-02-23
Q3 2019 -$6.25B +$1.09B +14.9% Sep 30, 2019 10-Q 2019-11-05
Q2 2019 -$6.38B +$1.4B +18% Jun 30, 2019 10-Q 2019-07-30
Q1 2019 -$6.53B +$1.8B +21.6% Mar 31, 2019 10-Q 2019-04-29
Q4 2018 -$6.95B +$1.44B +17.1% Dec 31, 2018 10-K 2020-02-25
Q3 2018 -$7.34B +$446M +5.73% Sep 30, 2018 10-Q 2018-10-29
Q2 2018 -$7.77B +$298M +3.69% Jun 30, 2018 10-Q 2018-07-31
Q1 2018 -$8.33B -$111M -1.35% Mar 31, 2018 10-Q 2018-05-01
Q4 2017 -$8.39B +$191M +2.23% Dec 31, 2017 10-K 2019-02-19
Q3 2017 -$7.79B +$921M +10.6% Sep 30, 2017 10-Q 2017-11-02
Q2 2017 -$8.07B +$866M +9.69% Jun 30, 2017 10-Q 2017-08-03
Q1 2017 -$8.22B +$510M +5.85% Mar 31, 2017 10-Q 2017-05-03
Q4 2016 -$8.58B +$346M +3.88% Dec 31, 2016 10-K 2018-02-20
Q3 2016 -$8.71B +$79M +0.9% Sep 30, 2016 10-Q 2016-11-03
Q2 2016 -$8.93B -$347M -4.04% Jun 30, 2016 10-Q 2016-08-03
Q1 2016 -$8.73B -$35M -0.4% Mar 31, 2016 10-Q 2016-05-04
Q4 2015 -$8.93B -$238M -2.74% Dec 31, 2015 10-K 2017-02-23
Q3 2015 -$8.79B -$396M -4.72% Sep 30, 2015 10-Q 2015-11-04
Q2 2015 -$8.59B -$155M -1.84% Jun 30, 2015 10-Q 2015-08-06
Q1 2015 -$8.69B -$254M -3.01% Mar 31, 2015 10-Q 2015-05-06
Q4 2014 -$8.69B -$119M -1.39% Dec 31, 2014 10-K 2016-02-24
Q3 2014 -$8.39B +$289M +3.33% Sep 30, 2014 10-Q 2014-11-05
Q2 2014 -$8.43B +$241M +2.78% Jun 30, 2014 10-Q 2014-08-06
Q1 2014 -$8.44B +$367M +4.17% Mar 31, 2014 10-Q 2014-05-08
Q4 2013 -$8.57B -$121M -1.43% Dec 31, 2013 10-K 2015-02-25
Q3 2013 -$8.68B -$168M -1.97% Sep 30, 2013 10-Q 2013-11-05
Q2 2013 -$8.67B -$827M -10.5% Jun 30, 2013 10-Q 2013-08-07
Q1 2013 -$8.8B -$4.54B -106% Mar 31, 2013 10-Q/A 2013-05-07
Q4 2012 -$8.45B -$4.07B -92.9% Dec 31, 2012 10-K 2014-02-26
Q3 2012 -$8.51B -$4.02B -89.6% Sep 30, 2012 10-Q 2012-11-06
Q2 2012 -$7.85B -$3.22B -69.5% Jun 30, 2012 10-Q 2012-08-07
Q1 2012 -$4.27B +$508M +10.6% Mar 31, 2012 10-Q 2012-05-03
Q4 2011 -$4.38B +$441M +9.15% Dec 31, 2011 8-K 2013-05-29
Q3 2011 -$4.49B +$570M +11.3% Sep 30, 2011 10-Q 2011-11-08
Q2 2011 -$4.63B +$618M +11.8% Jun 30, 2011 10-Q 2011-08-05
Q1 2011 -$4.78B +$570M +10.7% Mar 31, 2011 10-Q 2011-05-05
Q4 2010 -$4.82B Dec 31, 2010 10-K 2012-02-17
Q3 2010 -$5.06B Sep 30, 2010 10-Q 2010-11-05
Q2 2010 -$5.25B Jun 30, 2010 10-Q 2010-08-05
Q1 2010 -$5.35B Mar 31, 2010 10-Q 2010-05-06
* An asterisk sign (*) next to the value indicates that the value is likely invalid.